Parainfluenza
Infectious Diseases
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Ansun BioPharmaCA - San Diego
2 programs2
DAS181 dry powder, formulation F02Phase 21 trial
DAS181-F02 Dry Powder in BulkPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Ansun BioPharmaDAS181 dry powder, formulation F02
Ansun BioPharmaDAS181-F02 Dry Powder in Bulk
Clinical Trials (2)
Total enrollment: 134 patients across 2 trials
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
Start: Mar 2014Est. completion: Dec 2016111 patients
Phase 2Completed
An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection
Start: Aug 2013Est. completion: May 201723 patients
Phase 2Completed
Related Jobs in Infectious Diseases
Senior Recruiter
Invivyd
New Haven, CT (Northeast preferred)
5h ago
$120K - $160K/yr
Senior Associate Scientist (contract), Upstream Polysaccharide Process Development
VaxCyte
San Carlos, California, United States
8h ago
$56/hr
Senior Associate Scientist (contract), Polysaccharide Analytical Development
VaxCyte
San Carlos, California, United States
8h ago
$56/hr
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
12h ago
$179K - $237K/yr
First Line Sales Leader (Medan)
GSK
Indonesia - Sumatera Utara
Yesterday
General Worker
GSK
Pakistan - Sindh - Karachi
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space